Argent Biopharma Limited has released a press release.
Agreement for CBD Nutraceuticals Entry into China Market
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Received CannEpil Purchase Orders and Import Permit for UK
- MXCs 2019 Pharma Commercialisation Strategy
- Independent Validation of MXC High-Grade Cannabis Genetics
- MXC Botanical Update
- Completion of MGC Derma Sale to CannaGlobal
Later from Argent Biopharma
- New Distribution Agreements Signed for CannEpil & IMPs
- UK Distribution Agreement with Grow Biotech and IPS
- Arrival of First CannEpil Shipment to United Kingdom
- Cultivation Licence Granted by the Office of Drug Control
- Material Revenues Confirmed from Non-Pharma Business Units
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma